Source:http://linkedlifedata.com/resource/pubmed/id/12196481
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0017337,
umls-concept:C0017687,
umls-concept:C0020456,
umls-concept:C0032821,
umls-concept:C0221099,
umls-concept:C0301625,
umls-concept:C0332281,
umls-concept:C0871261,
umls-concept:C1416578,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1709866,
umls-concept:C1882417,
umls-concept:C2911692
|
pubmed:issue |
9
|
pubmed:dateCreated |
2002-8-28
|
pubmed:abstractText |
Genetic factors play an important role in the pathogenesis of type 2 diabetes. The relevance to type 2 diabetes of the common polymorphism Glu23Lys in the potassium inward rectifier 6.2 (KIR6.2) gene is still controversial. The aim of this study was to assess whether this polymorphism influences beta-cell function, alpha-cell function, or insulin action. We therefore studied 298 nondiabetic subjects using an oral glucose tolerance test (OGTT) and 75 nondiabetic subjects using a hyperglycemic clamp (10 mmol/l) with additional glucagon-like peptide (GLP)-1 and arginine stimulation. The prevalence of the Lys allele was approximately 37%, and the Lys allele was associated with higher incremental plasma glucose during the OGTT (P = 0.03, ANOVA). Neither first- nor second-phase glucose-stimulated C-peptide secretion was affected by the presence of the polymorphism; nor were maximal glucose-, GLP-1-, or arginine-induced C-peptide secretion rates; nor was insulin sensitivity (all P > 0.7). However, the relative decrease in plasma glucagon concentrations during the 10 min after the glucose challenge was reduced in carriers of the Lys allele (10 +/- 3% decrease from baseline in Lys/Lys, 18 +/- 2% in Glu/Lys, and 20 +/- 2% in Glu/Glu; P = 0.01, ANOVA). In conclusion, our findings suggest that the common Glu23Lys polymorphism in KIR6.2 is not necessarily associated with beta-cell dysfunction or insulin resistance but with diminished suppression of glucagon secretion in response to hyperglycemia. Our findings thus confirm its functional relevance for glucose metabolism in humans.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Glucagon,
http://linkedlifedata.com/resource/pubmed/chemical/Glutamic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Lysine,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channels, Inwardly...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0012-1797
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2854-60
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12196481-Adult,
pubmed-meshheading:12196481-Alleles,
pubmed-meshheading:12196481-Female,
pubmed-meshheading:12196481-Gene Frequency,
pubmed-meshheading:12196481-Glucagon,
pubmed-meshheading:12196481-Glutamic Acid,
pubmed-meshheading:12196481-Humans,
pubmed-meshheading:12196481-Hyperglycemia,
pubmed-meshheading:12196481-Insulin,
pubmed-meshheading:12196481-Islets of Langerhans,
pubmed-meshheading:12196481-Lysine,
pubmed-meshheading:12196481-Male,
pubmed-meshheading:12196481-Polymorphism, Genetic,
pubmed-meshheading:12196481-Potassium Channels, Inwardly Rectifying
|
pubmed:year |
2002
|
pubmed:articleTitle |
The prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (KIR6.2) gene is associated with impaired glucagon suppression in response to hyperglycemia.
|
pubmed:affiliation |
Department of Endocrinology, Metabolism and Pathobiochemistry, Medizinische Klinik, Eberhard-Karls-Universität, Tübingen, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|